A phase I/II study of oxaliplatin when added to 5-fluorouracil and leucovorin and pelvic radiation in locally advanced rectal cancer: a Colorectal Clinical Oncology Group (CCOG) study.
The purpose of this study was to evaluate the maximum tolerated dose (MTD) and recommended dose of oxaliplatin given synchronously with 5-fluorouracil (5FU), leucovorin (LV) and preoperative pelvic radiation for primary unresectable, locally advanced, rectal cancer. Preoperative pelvic radiotherapy...
Prif Awduron: | Sebag-Montefiore, D, Glynne-Jones, R, Falk, S, Meadows, H, Maughan, T |
---|---|
Fformat: | Journal article |
Iaith: | English |
Cyhoeddwyd: |
2005
|
Eitemau Tebyg
-
A phase I/II study of irinotecan when added to 5-fluorouracil and leucovorin and pelvic radiation in locally advanced rectal cancer: a Colorectal Clinical Oncology Group Study.
gan: Glynne-Jones, R, et al.
Cyhoeddwyd: (2007) -
Preliminary phase IISOCRATES study results: Capecitabine (CAP) combined with oxaliplatin (OX) and preoperative radiation (IRT) in patients (pts) with locally advanced rectal cancer (LARC).
gan: Glynne-Jones, R, et al.
Cyhoeddwyd: (2004) -
Socrates phase II study results: Capecitabine (CAP) combined with oxaliplatin (OX) and preoperative radiation (RT) in patients (pts) with locally advanced rectal cancer (LARC).
gan: Glynne-Jones, R, et al.
Cyhoeddwyd: (2005) -
OXALIPLATIN/5-FLUOROURACIL/LEUCOVORIN IN THE TREATMENT OF PATIENTS WITH METASTATIC COLORECTAL CANCER
gan: Deyan N. Davidov
Cyhoeddwyd: (2013-12-01) -
Evaluation of Antiemetic Therapy for Hepatic Arterial Infusion Chemotherapy with Oxaliplatin, Fluorouracil, and Leucovorin
gan: Zhao Y, et al.
Cyhoeddwyd: (2021-01-01)